Exscientia to Present at the BofA Securities 2022 Healthcare Conference
May 03 2022 - 4:30PM
Business Wire
Exscientia (Nasdaq: EXAI) today announced that Ben Taylor, CFO
& Chief Strategy Officer and Garry Pairaudeau, Chief Technology
Officer, will participate in a fireside chat at the BofA Securities
2022 Healthcare Conference on Tuesday, May 10, 2022 at 5:20 p.m.
P.T.
A live webcast of the fireside chat will be available on the
Company’s website, under the “Investors & Media” section at
www.investors.exscientia.ai. An archived replay of the webcast will
be available for approximately 30 days following the
presentation.
About Exscientia Exscientia is an AI-driven pharmatech
company committed to discovering, designing and developing the best
possible drugs in the fastest and most effective manner. Exscientia
developed the first-ever functional precision oncology platform to
successfully guide treatment selection and improve patient outcomes
in a prospective interventional clinical study, as well as to
progress AI-designed small molecules into the clinical setting. Our
pipeline demonstrates our ability to rapidly translate scientific
concepts into precision-designed therapeutic candidates, with more
than 30 projects underway. By designing better drugs, faster, we
believe the best ideas of science can rapidly become the best
medicines for patients.
Exscientia is headquartered in Oxford (England, U.K.), with
offices in Vienna (Austria), Dundee (Scotland, U.K.), Boston
(Mass., U.S.), Miami (Fla., U.S.), Cambridge (England, U.K.), and
Osaka (Japan).
Visit us at https://www.exscientia.ai or follow us on Twitter
@exscientiaAI.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220503006245/en/
Investors: Sara Sherman investors@exscientia.ai
Media: Amanda Galgay media@exscientia.ai
Exscientia (NASDAQ:EXAI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exscientia (NASDAQ:EXAI)
Historical Stock Chart
From Jul 2023 to Jul 2024